Skip to content

Bausch + Lomb BLCO Unrecognized Tax Benefits - Impacting Effective Tax Rate

Unrecognized Tax Benefits - Impacting Effective Tax Rate at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$0
Merck & Co. logo
Merck & Co.MRK
$2.5B+13.6%

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.43B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's unrecognized tax benefits - impacting effective tax rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's unrecognized tax benefits - impacting effective tax rate?
Bausch + Lomb (BLCO) reported unrecognized tax benefits - impacting effective tax rate of $62M in Q1 2026.
How has Bausch + Lomb's unrecognized tax benefits - impacting effective tax rate changed year-over-year?
Bausch + Lomb's unrecognized tax benefits - impacting effective tax rate increased by 12.7% year-over-year, from $55M to $62M.
What does unrecognized tax benefits - impacting effective tax rate mean?
This subset of unrecognized tax benefits represents positions that, if recognized, would directly impact the company's effective tax rate. It highlights the specific portion of tax uncertainty that carries a direct risk to the reported bottom-line tax expense. Investors monitor this to gauge the potential volatility of future tax provisions.